-
平臺編號：bio-49621
-
國際編號：ATCC VR-2379
-
拉丁屬名： Vaccinia virus
-
規(guī)格：frozen
-
用途：ATCC原裝進口
-
服務(wù)費用：
加載中…… - 訂購
-
注意事項：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準(zhǔn)）
Vaccinia virus
ATCC? Number:VR-2379?
Classification: Poxviridae, Orthopoxvirus
Agent: Vaccinia virus
Strain: RPmuhr23HA+ [recombinant of Utrecht strain RPuhr23]
Original Source: Vaccinia/rabbitpox recombinant
Depositors: University of Florida, Gainesville, RW Moyer, University of Florida, Gainesville
Biosafety Level:2
Shipped: frozen
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Host Organism : CV-1 (ATCCCCL 70); chicken embryo fibroblasts
Effect : Yes, in vitro effects: Cytopathic effects in tissue culture
Comments : Sequences cloned into pHGN3 (ATCC69051) can be integrated into this virus by transfection of a virus-infected host. [40815] Recombinants can be identified by inactivation of the hemagglutinin gene (HA-). [40815] This is a potential human pathogen. Parent strain RPuhr23 is a spontaneous white pock mutant of wild-type rabbitpox. The HA inserted in ATCCVR-2379 can serve as a cloning site for genes affecting vaccinia and rabbitpox. ATCC69051 is a shuttle vector for use with this system. Avirulent, hemagglutinin positive (HA+) recombinant, derived from the white pock deletion mutant of rabbit poxvirus. Part of a virulence testing system to be used with pHGN3 (ATCC69051). [40815] The insert contains approximately 443 bp 5' flanking sequence, 988 bp coding sequence and 408 bp 3' flanking sequence. [40815] Constructed by introducing the hemagglutinin gene from vaccinia virus IHD-J by homologous recombination. [40815]
References : 40815: Moyer RW, Bloom DC. Biological system for constructing and testing viral vaccines. US Patent 5,212,057 dated May 18 1993
Classification: Poxviridae, Orthopoxvirus
Agent: Vaccinia virus
Strain: RPmuhr23HA+ [recombinant of Utrecht strain RPuhr23]
Original Source: Vaccinia/rabbitpox recombinant
Depositors: University of Florida, Gainesville, RW Moyer, University of Florida, Gainesville
Biosafety Level:2
Shipped: frozen
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Host Organism : CV-1 (ATCCCCL 70); chicken embryo fibroblasts
Effect : Yes, in vitro effects: Cytopathic effects in tissue culture
Comments : Sequences cloned into pHGN3 (ATCC69051) can be integrated into this virus by transfection of a virus-infected host. [40815] Recombinants can be identified by inactivation of the hemagglutinin gene (HA-). [40815] This is a potential human pathogen. Parent strain RPuhr23 is a spontaneous white pock mutant of wild-type rabbitpox. The HA inserted in ATCCVR-2379 can serve as a cloning site for genes affecting vaccinia and rabbitpox. ATCC69051 is a shuttle vector for use with this system. Avirulent, hemagglutinin positive (HA+) recombinant, derived from the white pock deletion mutant of rabbit poxvirus. Part of a virulence testing system to be used with pHGN3 (ATCC69051). [40815] The insert contains approximately 443 bp 5' flanking sequence, 988 bp coding sequence and 408 bp 3' flanking sequence. [40815] Constructed by introducing the hemagglutinin gene from vaccinia virus IHD-J by homologous recombination. [40815]
References : 40815: Moyer RW, Bloom DC. Biological system for constructing and testing viral vaccines. US Patent 5,212,057 dated May 18 1993
